The genetic mutation that causes Huntington's disease may also enhance early brain development and promote intelligence.

Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...

Wave Life Sciences (WVE – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 12. Analyst ...

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

The show is a joint project by artists Bert and Elise Holland, Charlotte, Clair, Evie, Kate, Spencer James and Steven Hart.

Researchers uncover a link between impaired glutathione–ascorbate metabolism and early dopamine increases in Huntington's ...

Scientists have developed a novel polymer-based therapy that could slow Huntington's disease progression by preventing ...

Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

Research in mice is hinting at a possible means of slowing or stopping the disease In a Huntington's mouse model, rodents ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.